跳至主要内容
临床试验/NCT03197649
NCT03197649已完成不适用

Randomized, Prospective, Split Scar Pilot Study to Evaluate the Efficacy of CO2 Laser Phototherapy for Management of Mature Burn Scars

University of California, Davis2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2017年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Change in scar assessment evaluation

研究概览

简要总结

Evaluate mature burn scars before and after treatment with CO2 for patients age 3-21 while comparing the treated areas to an untreated control area in the same patient.

详细描述

Laser phototherapy has gained growing acceptance and popularity for management of burn scars. The most commonly used laser is the Carbon Dioxide (CO2) Laser. At this institution, the investigator has used CO2 for management of Burn Scars since 2012. While the existing literature and the investigator's anecdotal experience thus far has been positive overall, there is no conclusive evidence to support that CO2 does indeed improve the quality of mature burn scars

The primary objective of this study is to evaluate mature burn scars before and after treatment with CO2 for patients age 3-21 while comparing the treated areas to an untreated control area in the same patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participant is blinded

入排标准

年龄范围
3 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 3 to 21
  • Patients with mature burn scars that are at least two years old from burn injury and that have not previously undergone CO2 laser therapy for scar revision.
  • Scars in all body areas with the exception of face, genitals or hands will be considered eligible for the study
  • Entry into this study is open to pediatric patients of both genders.
  • Entry into this study is open to pediatric patients of all ethnic backgrounds.
  • Entry into this study is open to females of childbearing potential with a negative urine or serum pregnancy test

排除标准

  • Patients with scars less than 2 years old
  • Patients with contraindications to laser treatment (i.e.: active acne infections/ treatment with isotretinoin, active Zoster infection)
  • Patients receiving other forms of scar revision therapy such as other laser types, steroid injections, or surgical excisions.

结局指标

主要结局

Change in scar assessment evaluation

时间窗: Prior to initial treatment and no sooner than 3 months following last treatment

Patient and Observer Scar Assessment Scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验